Jingyu Deng

10PUBLICATIONS
15CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsMetabolic medicineMedical infection agents (incl. prions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Jun 17, 2026
LAMB3 drives gastric cancer progression through SAMD4A-mediated degradation of PHLPP2 mRNA leading to sustained PI3K-Akt activation.

|Jul 03, 2025
Conversion therapy with sintilimab combined with chemotherapy and apatinib in stage IV gastric cancer.

Yong Liu, Qiang Xue, Baogui Wang

|Apr 26, 2024
ACAT2 suppresses the ubiquitination of YAP1 to enhance the proliferation and metastasis ability of gastric cancer via the upregulation of SETD7.

Mengmeng Zhang, Fenglin Cai, Jiamei Guo

|Jan 06, 2024
EGLN3 attenuates gastric cancer cell malignant characteristics by inhibiting JMJD8/NF-κB signalling activation independent of hydroxylase activity.

Fenglin Cai, Xiuding Yang, Gang Ma

|Aug 16, 2023
Combining methylated SEPTIN9 and RNF180 plasma markers for diagnosis and early detection of gastric cancer.

Yongzhan Nie, Xianchun Gao, Xiqiang Cai

|Jun 29, 2023
SMYD3 drives the proliferation in gastric cancer cells via reducing EMP1 expression in an H4K20me3-dependent manner.

Yi Zeng, Gang Ma, Fenglin Cai

Pageof 2

Frequent Collaborators

4 joint publications

Han Liang

4 joint publications

Gang Ma

2 joint publications

Yongzhan Nie

2 joint publications

Fenglin Cai